MedTrace Logo

The Complete® Self-Expanding Stent and Stent Delivery System Registry

NCT00730730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-04-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to show if a new delivery system with a modified stent is safe in treating occluded iliac arteries in patients with peripheral vascular disease. The modified Complete SE delivery system is hypothesized to assist physicians with more accurate stent placement reducing the likelihood of stent 'jumping' seen with the use of many self-expanding stent systems.

Conditions

  • Peripheral Vascular Disease

Interventions

DEVICE

Complete SE Iliac Stent

Iliac stenting

DEVICE

Complete SE Iliac Stent

Self-expanding stent

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Robert G Molnar, MD · Michigan Vascular Research Center

  • William Gray · New York Presbyterian Hospital/Columbia Campus

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-02-28
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730730 on ClinicalTrials.gov